These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6281475)

  • 1. Use of fluoresceinated Epstein-Barr virus to study Epstein-Barr virus-lymphoid cell interactions.
    Khelifa R; Menezes J
    J Virol; 1982 Feb; 41(2):649-56. PubMed ID: 6281475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction.
    Stocco R; Sauvageau G; Menezes J
    Virus Res; 1988 Oct; 11(3):209-25. PubMed ID: 2848382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-lymphoid cell interactions. III. Effect of concanavalin A and saccharides on Epstein-Barr virus penetration.
    Khélifa R; Menezes J
    J Virol; 1982 May; 42(2):402-10. PubMed ID: 6283164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sendai virus envelopes can mediate Epstein-Barr virus binding to and penetration into Epstein-Barr virus receptor-negative cells.
    Khélifa R; Menezes J
    J Virol; 1983 Apr; 46(1):325-32. PubMed ID: 6298467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes.
    Sauvageau G; Stocco R; Kasparian S; Menezes J
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():379-86. PubMed ID: 2155291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in viral binding between two Epstein-Barr virus substrains to a spectrum of receptor-positive target cells.
    Wells A; Koide N; Klein G
    Int J Cancer; 1981 Mar; 27(3):303-9. PubMed ID: 6270014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
    Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
    Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes.
    Steinitz M; Bakács T; Klein G
    Int J Cancer; 1978 Sep; 22(3):251-7. PubMed ID: 212371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
    Takimoto T; Umeda R
    Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.
    Blazar B; Patarroyo M; Klein E; Klein G
    J Exp Med; 1980 Mar; 151(3):614-27. PubMed ID: 6244358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of human epithelial cells by Epstein-Barr virus (EBV). II. Biochemical characterization of EBV-determined proteins synthesized in epithelial cells.
    Sinangil F; Volsky B; Volsky DJ
    Virus Res; 1985 Oct; 3(3):207-12. PubMed ID: 3000099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation of a hydrocarbon fluorescent probe between Epstein-Barr virus and lymphoid cells: an assay for early events in viral infection.
    Rosenthal KS; Yanovich S; Inbar M; Strominger JL
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5076-80. PubMed ID: 217012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
    Patel PC; Menezes J
    Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells.
    Haddad RS; Hutt-Fletcher LM
    J Virol; 1989 Dec; 63(12):4998-5005. PubMed ID: 2555536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
    Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
    Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR; Mold C; Schwend VK; Tollefson V; Cooper NR
    J Virol; 1987 May; 61(5):1416-20. PubMed ID: 3033269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.